Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults - Report - MDSpire

Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults

  • By

  • Charlotte E. Joslin

  • Angie Wang

  • David J. Lee

  • Lawrence J. Ulanski

  • Byron L. Lam

  • Thasarat S. Vajaranant

  • Carlos E. Mendoza-Santiesteban

  • Michael L. Stewart

  • Giselle Gutierrez Savoy

  • Mehmet Cem Mocan

  • Franklyn Gonzalez

  • D. Diane Zheng

  • Bharat Thyagarajan

  • Laura Coco

  • Amber Pirzada

  • Jianwen Cai

  • Martha L. Daviglus

  • SOL Ojos Study Group

  • Giselle A. Gutierrez Savoy

  • Heather Pauls Hrynyk

  • Angie Wang

  • Raiza Perez Lucena

  • Chunyu Guo

  • Evelyn Ramirez

  • Patrizia A. Chavero

  • Lucila Suarez

  • Banelly Mora

  • Sydney Tobias

  • Manishi A. Desai

  • Pathik P. Amin

  • Hannah Yoon

  • Charles W. Kinnaird

  • Ramón A. Durazo-Arvizu

  • Margaret Weiss

  • Norma Del Risco

  • David J. Lee

  • Stephanie Negron

  • Byron Lam

  • Diane Zheng

  • Neil Schneiderman

  • Laura A. McClure

  • Miguel Valladares Regalado

  • Tamara Juvier-Riesgo

  • Liliana Rosello-Rodriguez

  • Estefania Ruano-Herreria

  • Maia Junco

  • Diana Hernandez Payano

  • Richard Ramos

  • Eliseo Moreno Perez

  • Maria Cristina Buhl

  • Jianwen Cai

  • Franklyn Gonzales

  • Marston Youngblood Jr.

  • Maryann Redford

  • Jimmy T. Le

  • Karla Zadnik

  • Juan E. Grunwald

  • Henry D. Jampel

  • Aracely Rosales

  • Brisa N. Sánchez

  • Sheila K. West

  • Siew Wei Gavin Tan

  • Yi Chong Teo

  • Haslina Hamzah

  • Shu Chin Serene Sim

  • Amalia Juhari

  • Muhamad Asri Abdul Kadir

  • Raudhah Hanim Mohamed Yusof

  • Xingxiu Ho

  • Jinyi Ho

  • Nishal Banu Makdoom

  • Kayathri Jaya Paul

  • Sharifah Athirah Diba Sagoff

  • June 12, 2026

  • 0 min

Share

Cardiovascular Risk Factors and Visual Impairment Among Hispanic and Latino Adults

Overview

This study investigates the prevalence of visual impairment (VI) among Hispanic and Latino adults, highlighting significant associations with cardiovascular disease (CVD) risk factors. The findings underscore the need for targeted interventions to address VI in this population, given the high burden of CVD risk factors.

Background

Visual impairment is a major public health concern, affecting millions and leading to adverse health outcomes. Hispanic and Latino populations in the U.S. are particularly affected, with a notable prevalence of VI linked to chronic diseases such as diabetes and hypertension. Understanding the relationship between CVD risk factors and VI is crucial for improving health outcomes in these communities.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

  • VI prevalence varies across different Hispanic/Latino backgrounds.
  • Cardiovascular risk factors such as diabetes, hypertension, and obesity are prevalent in Hispanic/Latino adults.
  • VI is defined as visual acuity less than or equal to 20/40 based on habitual and best-corrected measurements.
  • Uncorrected refractive error is a significant contributor to VI in this population.
  • The study utilized comprehensive eye examinations to assess VI and its associations with CVD risk factors.

Clinical Implications

Healthcare providers should prioritize screening for visual impairment among Hispanic and Latino adults, particularly those with known cardiovascular risk factors. Addressing these risks through targeted interventions may help reduce the burden of visual impairment in this population.

Conclusion

The study highlights the critical link between cardiovascular risk factors and visual impairment among Hispanic and Latino adults, emphasizing the need for integrated healthcare approaches to address these interconnected health issues.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Retinal Physician, 2024 -- Cardiovascular Health Linked to Lower Retinopathy Risk in US Adults
  3. Optometric Management, 2026 -- Latinos en Optometry Highlights Patient Care Challenges With Cataract
  4. JAMA Ophthalmology -- Prevalence and Health Care Disparities of Retinal Conditions
  5. PMC, 2026 -- Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes
  6. Ophthalmology Management — Glaucoma’s growing prevalence in the US
  7. Prevalence and Health Care Disparities of Retinal Conditions
  8. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 - PMC
  9. Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease - Professional Heart Daily | American Heart Association

Original Source(s)

Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults

  • by Charlotte E. Joslin, Angie Wang, David J. Lee, Lawrence J. Ulanski, Byron L. Lam, Thasarat S. Vajaranant, Carlos E. Mendoza-Santiesteban, Michael L. Stewart, Giselle Gutierrez Savoy, Mehmet Cem Mocan, Franklyn Gonzalez, D. Diane Zheng, Bharat Thyagarajan, Laura Coco, Amber Pirzada, Jianwen Cai, Martha L. Daviglus, SOL Ojos Study Group, Giselle A. Gutierrez Savoy, Heather Pauls Hrynyk, Angie Wang, Raiza Perez Lucena, Chunyu Guo, Evelyn Ramirez, Patrizia A. Chavero, Lucila Suarez, Banelly Mora, Sydney Tobias, Manishi A. Desai, Pathik P. Amin, Hannah Yoon, Charles W. Kinnaird, Ramón A. Durazo-Arvizu, Margaret Weiss, Norma Del Risco, David J. Lee, Stephanie Negron, Byron Lam, Diane Zheng, Neil Schneiderman, Laura A. McClure, Miguel Valladares Regalado, Tamara Juvier-Riesgo, Liliana Rosello-Rodriguez, Estefania Ruano-Herreria, Maia Junco, Diana Hernandez Payano, Richard Ramos, Eliseo Moreno Perez, Maria Cristina Buhl, Jianwen Cai, Franklyn Gonzales , Marston Youngblood Jr., Maryann Redford, Jimmy T. Le, Karla Zadnik, Juan E. Grunwald, Henry D. Jampel, Aracely Rosales , Brisa N. Sánchez, Sheila K. West, Siew Wei Gavin Tan, Yi Chong Teo, Haslina Hamzah, Shu Chin Serene Sim, Amalia Juhari, Muhamad Asri Abdul Kadir, Raudhah Hanim Mohamed Yusof, Xingxiu Ho, Jinyi Ho, Nishal Banu Makdoom, Kayathri Jaya Paul, Sharifah Athirah Diba Sagoff

  • June 12, 2026

Related Content

Steroid Strategies in Diabetic Macular Edema

Retina Biomarkers for Treatment Selection in DME

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.